Concentra Group Holdings Parent, Inc. (CON) - Stock Analysis
Last updated: Aug 22, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q2 revenue rose 10%, net income 46.5%, and adjusted EBITDA 22.5%; EPS beat consensus, full-year guidance was raised, and the stock gained 11.8% over 21 sessions with a rising moving average.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Expansion ⢠Strong Cash Flow ⢠Elevated Leverage CON shows improving profitability, cash flow, and liquidity, but high leverage, limited interest cushion, and elevated valuation leave little room for disappointment.
Price Behavior
Key Price Behavior Insights: ⢠Strong Uptrend ⢠Elevated Momentum ⢠Breakout Volatility Support Level: $34.00â$34.50; stronger support $31.60â$31.90 Resistance Level: $35.50 CON rose 10.7% over the last month and remains bullish above $34, but RSI near 72 and resistance at $35.50 suggest elevated pullback risk toward $34.00â$34.50 or $31.60â$31.90.
Sentiment & News
Key News Insights: ⢠Strong Q2 Results ⢠Raised Guidance ⢠Leadership Transition Concentra delivered strong Q2 growth, raised 2026 guidance, expanded its network, and announced leadership succession, reinforcing positive momentum for CON.
AI Summary
CON is shifting from a footprint-expansion story to an operating-leverage and free-cash-flow thesis, but investors should prioritize debt reduction and verify sustainable organic growth and acquisition integration before chasing momentum at current valuation.
Description
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational and consumer health services, operating clinic networks and onsite programs that deliver workersâ compensation care, urgent care, preventive and clinical testing, and employer health services. The company also offers telemedicine for work-related conditions, pharmacy services, and third-party administration for medical compliance and drug testing. Founded in 1979 and headquartered in Mechanicsburg, Pennsylvania, Concentra is a subsidiary of Select Medical Corporation.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Aug 26 | Sep 2 | CON | Concentra Group Holdings Parent, Inc. | Q2 revenue rose 10%, net income 46.5%, and adjusted EBITDA 22.5%; EPS beat consensus, full-year guidance was raised, and the stock gained 11.8% over 21 sessions with a rising moving average. | Active | +0.0% |